2022 International Congress » Parkinson's Disease: Cognitive functions

Meeting: 2022 International Congress

A PROSPECTIVE COHORT STUDY OF COGNITIVE IMPAIRMENT AND CORTISOL LEVELS IN PARKINSON’S DISEASE

N. Soares, G. Pereira, A. Dutra, N. Artigas, J. Krimberg, B. Monticelli, A. Schumacher-Schuh, R. de Almeida, C. Rieder (Porto Alegre, Brazil)

A second level neuropsychological battery for Parkinson’s Disease. Normative data from the Italian population.

T. Gandolfi, G. Arcara, S. Cuoco, C. Siri, L. Weis, E. Reali, M. Garon, F. Pistonesi, V. Cianci, E. Fiorenzato, G. Santangelo, G. Pezzoli, P. Barone, A. Antonini, R. Biundo (Padova, Italy)

Are Subjective Cognitive Complaints a predictor of future cognitive decline in Parkinson´s Disease? – A longitudinal study

M. Magriço, B. Meira, M. Fernandes, M. Saraiva, M. Salavisa, C. Borbinha, J. Maro, F. Ladeira, R. Barbosa, P. Bugalho (Lisboa, Portugal)

Blood Lipid Biomarkers in Early Parkinson Disease and Parkinson Disease with Mild Cognitive Impairment

DX. Deng, LT. Tan (Singapore, Singapore)

Boostering motor imagery processing to improve gait in patients with Parkinson disease and freezing of gait: a preliminary study

S. Mezzarobba, E. Ravizzotti, P. Bernardis, M. Putzolu, C. Cosentino, A. Botta, G. Bonassi, R. Marchese, L. Avanzino, E. Pelosin (Genoa, Italy)

Chronotype and Cognition in Veterans with Parkinson’s Disease

A. Sarwar (Houston, USA)

Clinical characteristics in de-novo PD patients with reversible vs. progressive cognitive dysfunction during long-term follow-up

K. Kawabata, A. Djamshidian-Tehrani, K. Seppi, W. Poewe (Innsbruck, Austria)

Cognition in parkinson disease: Tunisian clinical experience

F. Syrine, B. Nadia, H. Hela, F. Saloua, B. Mariem, FRE. Mohamed (tunis, Tunisia)

Cognitive and Functional Trajectories in Prediagnostic Parkinson’s Disease

M. Bock, E. Vittinghoff, A. Bahorik, Y. Leng, K. Yaffe (San Francisco, USA)

Cognitive Function in Late-life and Parkinson’s Disease Neuropathology at Death

R. Abbott, G. Ross, H. Petrovitch, K. Masaki, J. Uyehara-Lock, C. Tanner (Ansan-si, Republic of Korea)

Cognitive performance and learning parameters predict response to working memory training in Parkinson’s disease

A. Ophey, J. Wenzel, R. Paul, K. Giehl, C. Eggers, P. Reker, T. van Eimeren, E. Kalbe, L. Kambeitz-Ilankovic (Cologne, Germany)

Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.

S. Mirza, S. Duff-Canning, M. Masellis, C. Marras (Toronto, Canada)

Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan

A. Il'Yazova, C. Shambetova, E. Zhunusova (Bishkek, Kyrgyzstan)

Correlation between clinical scales and gait in Parkinson’s disease

A. Bitiati, C. de Oliveira, R. Treza, S. Hondo, E. Angeles, C. Bernardo, L. de Oliveira, M. Carvalho, M. Golin, D. Coelho (Santo André, Brazil)

Correlation between cognitive/emotional factors and postural control in patients with Parkinson’s disease

A. Bitiati, C. de Oliveira, C. de Souza, A. Batista, R. Marquesini, A. Moreira-Neto, C. Batista, L. Teixeira, A. Pardini, D. Coelho (Santo André, Brazil)

Data-driven identification of distinct fronto-subcortical and cortical-posterior subtypes of cognitive decline in Parkinson’s disease

M. Grothe, M. Labrador-Espinosa, S. Jesús, F. Roldán Lora, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, SG. Coppadis, P. Martínez-Martín, J. Kulisevsky, D. Santos-García, P. Mir (Seville, Spain)

Differences between two cognitive assessment instruments used in Parkinson’s disease in Kyrgyzstan

E. Zhunusova, C. Shambetova, A. Il'Yazova (Bishkek, Kyrgyzstan)

Do clinical neuropsychological tasks capture visuoperceptual deficits in culturally-diverse individuals with Parkinson’s disease and hallucinations?

S. Adamo, M. Statucka, M. Cohn (Toronto, Canada)

Dopaminergic medication improves movement vigour in Parkinson’s but not the adaptation of movement speed to curvature

L. Hickman, D. Fraser, J. Galea, J. Cook (Birmingham, United Kingdom)

Embodied language in Parkinson disease: the case of demonstrative

C. Giacobbe, Y. Coello, G. Santangelo (Caserta, Italy)

Emotion Recognition and Risk-Taking Behaviour in Early Parkinson’s Disease

A. Slomp, D. de Waard, S. Vander Zee, S. Slingerland, J. Boertien, J. Spikman, T. van Laar, R. Huitema (Groningen, Netherlands)

Emotion Recognition in Multiple System Atrophy – an Eye-Tracking Study

V. Sidoroff, F. Carbone, P. Ellmerer, S. Bair, A. Hoffmann, T. Maran, C. Raccagni, K. Seppi, G. Wenning, A. Djamshidian-Tehrani (6020, Austria)

Evaluation of the association between total electrical energy delivered (TEED) and cognitive function six months after DBS in patients with Parkinson’s disease

F. Ruggiero, F. Mameli, M. Dini, S. Marceglia, M. Prenassi, L. Borellini, F. Cogiamanian, E. Pirola, E. Zirone, D. Mellace, B. Capetti, L. Remore, G. Fiore, MR. Reitano, N. Maiorana, M. Locatelli, S. Barbieri, A. Priori, R. Ferrucci (Milan, Italy)

Examining adaptive control in patients with Parkinson’s disease

J. Kricheldorff, J. Ficke, K. Witt (Oldenburg, Germany)

Expression perception and timing in people with Parkinson’s Disease

M. Gracey, C. Press, J. Cook (Birmingham, United Kingdom)

Face Name matching and memory complaints in Parkinson’s disease

A. Siquier, P. Andrés (Palma, Spain)

Facial emotion recognition in Parkinson’s disease: the role of executive and affective domains

A. Siquier, P. Andrés (Palma, Spain)

Freezing of Gait Can Predict Cognitive Decline in Parkinson’s Disease

Y. Qu, JT. Li, YP. Chen, JY. Li, QX. Qin, DL. Wang, JW. Zhao, ZJ. Mao, YJ. Xiong, Z. Min, Z. Xue (Wuhan, China)

Genetic contribution to domain specific cognitive decline

V. Livneh, N. Omer, N. Giladi, T. Gurevich, A. Bar-Shira, M. Gana-Weisz, O. Goldstein, J. Shirvan, J. Cedarbaum, A. Orr-Urtreger, R. Alcalay, A. Mirelman, A. Thaler (Tel Aviv, Israel)

High- and Low-Frequency Deep Brain Stimulation in the Subthalamic Nucleus differentially modulate Response Inhibition and Action Selection in Parkinson’s Disease

J. Waldthaler, A. Sperling, A. König, F. Bremmer, L. Timmermann, D. Pedrosa (Marburg, Germany)

History of Comorbidities and their Association with Developing Cognitive Dysfunction in PD

C. Venuto, K. Kieburtz, K. Herbst, G. Smith (Rochester, USA)

Impact of ApoE genotype on cognition in idiopathic and genetic forms of Parkinson’s disease

C. Koros, K. Brockmann, Aμ. Simitsi, A. Bougea, H. Liu, ακ. Hauser, C. Schulte, I. Pachi, N. Papagiannakis, A. Zahou, I. Wurster, E. Efthymiopoulou, I. Beratis, R. Antonelou, M. Maniati, M. Moraitou, H. Michelakakis, G. Paraskevas, S. Papageorgiou, C. Potagas, D. Papadimitriou, M. Bozi, M. Stamelou, T. Gasser, L. Stefanis (Athens, Greece)

Impact of DBS on cognitive functions in Parkinson’s disease in 1 year follow-up

A. Martinkovičová, Z. Košutzká, M. Pápayová, I. Straka, M. Kľoc, P. Valkovič (Bratislava, Slovakia)

Impact of the dopamine system on long-term, incident cognitive impairment in Parkinson disease

D. Weintraub, M. Picillo, H. Cho, C. Caspell-Garcia, C. Coffey, K. Marek, K. Poston, T. Simuni, J. Seibyl, A. Siderowf, A. Singleton, C. Tanner (Philadelphia, USA)

Impaired behavioral proactive inhibitory control and flexibility in a mouse model of early Parkinson’s disease

J. Lhost, AM. Ouagazzal, M. Liberge, M. Amalric (Marseille, France)

Influence of alcohol consumption on cognitive decline in Parkinson disease.

E. Ruiz-Fernández, J. Marín-Lahoz, J. Pagonabarraga, A. Horta-Barba, S. Martínez-Horta, H. Bejr-Kasem, I. Aracil-Bolaños, A. Campolongo, J. Kulisevsky (Zaragoza, Spain)

Language Impairment in Isolated Rapid Eye Movement Sleep Behavior Disorder and de-novo Parkinson’s disease

M. šubert, M. šimek, M. Novotný, T. Tykalová, O. Bezdíček, E. Růžička, K. šonka, P. Dušek, J. Rusz (Prague 6, Czech Republic)

Longitudinal Assessessment of Social Cognition in de novo PD patients and its Relationship with Striatal Dopaminergic Innervation

C. Trompeta, C. Gasca-Salas, JA. Pineda Pardo, P. Guida, D. Mata-Marín, M. Hg Monje, A. Sánchez-Ferro, I. Obeso, JA. Obeso (Móstoles, Spain)

Longitudinal predictors of functional dependence in a multicentric Parkinson’s Disease cohort

S. Becker, B. Callahan (Calgary, Canada)

Lymphocyte count/neutrophil-to-lymphocyte ratio and mild cognitive impairment in Parkinson’s disease

E. Contaldi, L. Magistrelli, S. Gallo, C. Comi (Novara, Italy)

MoCA and MMSE subitems’ sensitivity across the PD-cognitive spectrum

E. Fiorenzato, L. Zurlo, C. Cianci, M. Garon, T. Gandolfi, F. Pistonesi, L. Weis, A. Antonini, R. Biundo (Padua, Italy)

Montreal Cognitive Assessment cutoff point for cognitive impairment in Mexican subjects with PD: A neuropsychological approach

AJ. Hernández-Medrano, GI. Cerda-Hernández, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, MA. Ruiz-Mafud, RA. Abundes-Corona, G. Sánchez-Dinorín, E. Lobato-Ildefonso, A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Solís-Vivanco (Mexico City, Mexico)

Motor resonance flexibility to emotion-enriched context in Parkinson’s disease patients with and without freezing of gait.

E. Pelosin, G. Lagravinese, A. Bisio, M. Bove, A. Botta, G. Bonassi, R. Marchese, S. Mezzarobba, P. Ruggeri, L. Avanzino (Genova, Italy)

NIMHANS Neuropsychological Battery for Elderly in Parkinson’s disease patients: Validation and diagnosis using MDS PD-MCI task force criteria in Indian population

R. Yadav, R. Botta, K. Kumar, BM. Kutty, A. Mahadevan, PK. Pal (Bengaluru, India)

PD-MCI is frequent in candidates to subthalamic deep brain stimulation and is associated with structural brain alterations

K. Dujardin, Q. Devignes, S. Daoudi, R. Viard, R. Lopes, N. Betrouni, G. Kuchcinski, AS. Rolland, JC. Corvol, D. Devos (Lille, France)

Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after 2 years Subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)

C. García-Sánchez, C. Pons, N. Grunden, B. Pascual-Sedano, A. Gironell, R. Rodriguez, J. Kulisevsky (Barcelona, Spain)

Plasma Alzheimer’s disease biomarkers and cognitive progression in Parkinson’s disease

A. Pilotto, NJ. Ashton, A. Lupini, B. Battaglio, S. Gipponi, E. Cottini, I. Grossi, A. Salvi, G. de Petro, M. Pizzi, K. Blennov, M. Gonzalez, D. Aarsland, H. Zetterberg, A. Padovani (Brescia, Italy)

Plasma p-Tau181 and p-Tau231 in Parkinson’s Disease

MC. Gonzalez, NJ. Ashton, A. Pilitto, A. Padovani, B. Fernandes Gomes, DA. Tovar-Rios, F. Blanc, A. Lemstra, C. Paquet, C. Abdelnour, M. Boada, L. Bonanni, R. Vandenberghe, K. Blennow, H. Zetterberg, D. Aarsland (Stavanger, Norway)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

L. Batzu, S. Rota, A. Hye, A. Heslegrave, D. Trivedi, L. Gibson, C. Farrell, P. Zinzalias, A. Rizos, H. Zetterberg, K. Ray Chaudhuri, D. Aarsland (London, United Kingdom)

Predicting the development of dementia in patients with Parkinson’s disease by comparing neurosteroids in the blood level

DI. Okhunova, G. Sattarovna, A. Babokhujaev (Tashkent, Uzbekistan)

Preliminary results on the cognitive profile in prodromal Parkinson’s disease – a prospective study

L. Pauly, M. Hansen, C. Pauly, A. Leist, R. Krüger (Strassen, Luxembourg)

Priorities of PD patients for treatment of cognitive-driven ADL impairment

I. Liepelt-Scarfone, M. Bentele, S. Becker, C. Altmann, E. Schaeffer, K. Michaelis, S. Solbrig, K. Brockmann (Tübingen, Germany)

Progressive Supranuclear Palsy (PSP) Vs Parkinson’s Disease (PD) – Whether Frontal Assessment Battery (FAB) Can Differentiate

M. Kulsum, D. Das, S. Ananad (Kolkata, India)

Psychometric properties and construct validity of the Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) in Colombia.

B. Muñoz-Ospina, H. Clavijo-Moran, D. álvarez-García, G. Pinilla-Monsalve, J. Orozco Velez (Cali, Colombia)

Relationship between cardiovascular autonomic failure and cognitive performance in the α-synucleinopathies: preliminary cross-sectional analysis of the NHSS registry

N. Campese, L. Weissmantel, K. Kerer, F. Leys, G. Goebel, L. Zamarian, C. Raccagni, S. Eschlboeck, C. Eckhardt, V. Sidoroff, F. Krismer, R. Granata, M. Perez, J. Palma, P. Millar-Vernetti, R. Ceravolo, S. Kiechl, W. Poewe, K. Seppi, H. Kaufmann, L. Norcliffe-Kaufmann, G. Wenning, A. Fanciulli (Innsbruck, Austria)

Relationship between cholinergic basal forebrain volume and short-latency sensory afferent inhibition in Parkinson’s disease with varying degrees of cognitive performance

JF. Martín-Rodríguez, P. Franco Rosado, E. Iglesias Camacho, AM. Castellano-Gerrero, MA. Labrador-Espinosa, B. Villarreal, L. Muñoz-Delgado, D. Macías-García, P. álvarez Toledo, M. San Eufrasio, M. Reina Castillo, S. Jesús, A. Adarmes-Gómez, F. Carrillo, MJ. Grothe, P. Mir (Sevilla, Spain)

SelfCog®: a digitized cognitive battery to classify Parkinson disease (PD) patients with or without Mild Cognitive Impairment (MCI)

J. Montillot, R. Massart, K. Hernandez, M. Lunven, G. Fénelon, H. Salhi, A. Bachoud-Lévi, P. Rémy (Créteil, France)

Sex Differences for Tau Association with Cognition in Early Parkinson’s Disease

E. Bayram, A. Tsai, K. Wang, I. Litvan (La Jolla, USA)

Social cognition in Parkinson’s disease

G. Siripurapu, R. Rajan, D. M R, E. A, A. Gupta, V. V Y, M. Singh, R. Bhatia, M. Tripathi, A. Srivastava, M. Srivastava, B. Verma, D. Biswas (NEW DELHI, India)

The association of CSF sTREM2 with cognitive decline and its dynamic change in Parkinson’s disease: Analysis of the PPMI Cohort

Q. Qixiong, W. Hengming, W. Danlei, L. Jingyi, Q. Yi, Z. Jingwei, L. Jiangting (Wu han, China)